Laboratories and disease surveillance.

Current disease tracking in the U.S. relies heavily on lab testing and reporting. Clinical labs handle most initial disease reports and send samples to public health labs for confirmation. Public health labs perform specialized tests to identify disease clusters and sources. They also offer unique diagnostic services and train other labs. However, changes in healthcare are affecting lab operations. Fewer isolates are available for analysis, and relationships between labs have shifted. This threatens the ability to monitor diseases effectively. Maintaining a strong lab network is essential for disease control. A national testing system is proposed to address these challenges.

This analysis aims to highlight threats to disease surveillance from healthcare changes. It examines how lab testing and reporting support disease monitoring. The focus is on the role of clinical and public health labs in tracking infections. The study identifies declining isolate availability and shifting lab relationships. It emphasizes the need for a coordinated testing network. The goal is to preserve the infrastructure for disease control. The authors assess the current state of lab-based surveillance. They propose solutions to maintain surveillance effectiveness.

The authors review the structure of the U.S. disease surveillance system. They analyze the roles of clinical and public health laboratories. Data on testing volumes and sample referrals are examined. Changes in healthcare delivery and lab operations are considered. The study evaluates the impact of reduced isolate availability. It assesses the effects of shifting lab relationships. The authors compare historical and current lab practices. They propose a national system for public health testing.

Clinical labs report most diseases and refer samples to public health labs. Public health labs perform specialized typing and confirmation. They also provide training and quality assurance for clinical labs. However, fewer isolates are available for analysis in recent years. Public health lab testing volumes have declined. Relationships between clinical and public health labs have changed. These changes threaten surveillance effectiveness. A national testing system is needed to maintain disease control.

The U.S. disease surveillance system depends on clinical and public health labs. Declining isolate availability and shifting lab relationships pose risks. Public health labs provide essential typing and confirmation services. They also train clinical labs and handle unique diagnostic requests. A national testing system is necessary to sustain surveillance. Maintaining lab networks is critical for disease control. The authors emphasize the importance of coordinated testing efforts. They highlight the need for infrastructure to support public health goals.